What sector is CLYM in?

Climb Bio, Inc. Common Stock (CLYM) operates in the Healthcare sector, specifically in the PHARMACEUTICAL PREPARATIONS industry.

What is CLYM's market cap?

Climb Bio, Inc. Common Stock (CLYM) has a market capitalization of $442M.

How can I analyze CLYM stock?

Valhalla provides comprehensive analysis for CLYM including institutional trade flow, dark pool activity, options data, technical indicators, and proprietary scoring. Visit valhalla-labs.io/stocks/CLYM for a full breakdown.

Where can I find institutional trades for CLYM?

Valhalla tracks real-time institutional trade flow for CLYM, including dark pool blocks, lit block trades, and sweep orders. These insights help identify where smart money is positioned.

CLYM

Q: What is CLYM (Climb Bio, Inc. Common Stock)?

Climb Bio, Inc. Common Stock (CLYM) is a healthcare company in the pharmaceutical preparations industry. Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune d

Climb Bio, Inc. Common Stock

Healthcare — PHARMACEUTICAL PREPARATIONS

Valhalla Score 77

$8.92

Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Latest Healthcare Sector News

ROSEN, A LEADING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGCNew York, New York--(Newsfile Corp. - May 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Regencell Bioscie...newsfilecorp.com — May 1, 2026

CLYM Data Insights

Dark pool activity detected in the last 5 trading days

Subscribe for full dark pool analysis, institutional flow, and real-time alerts.

📊 Key Statistics

Market Cap$442M

P/E Ratio—

EPS (TTM)—

EPS YoY—

Revenue YoY—

Float—

Short Float %—

Inst. Ownership—

Sector RS—

📈 Fundamentals

ROE—

ROIC—

ROA—

Current Ratio—

Debt/Equity—

Gross Margin—

Net Margin—

Dividend Yield—

Next Earnings—

⚡ Options Summary

Call OI—

Put OI—

P/C Ratio (OI)—

Gamma Environment—

Max Pain—

Call Wall—

Put Wall—

🎯 Analyst Estimates

Consensus Target—

High Target—

Low Target—

Analysts—

Upside/Downside—

📋 Quarterly Financials

Period	Revenue	Rev YoY	EPS	EPS YoY	Gross Margin

Start Free Trial See full options flow, dark pool data & more

🔥 Recent Options Flow

Type	Strike	Exp	Size	Premium	Time

Start Free Trial Institutional trades, dark pool vs lit exchange

🏛️ Institutional Trades

Type	Price	Size	Value	Venue	Time

Start Free Trial Full insider & congressional trade history

👤 Insider Trades

Name	Type	Shares	Price	Date

Start Free Trial Top institutional holders & ownership data

🏦 Top Institutional Holders

Institution	Shares	Value	% of Class